🔎 Trials Near Me

Home › Astrocytoma › Massachusetts › Boston

Astrocytoma clinical trials in Boston, MA

13 studies for Astrocytoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

RecruitingPhase 3
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT07215910

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

RecruitingPhase 1/2
  • Tufts Medical Center, Boston
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06047379

Targeted Pediatric High-Grade Glioma Therapy

RecruitingObservational study
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · All sexes · Updated Sep 8, 2026 · NCT05839379

Serial MRI Scans During Radiation Therapy

Recruiting
  • Brigham and Women Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04188535

Study of Olutasidenib and Temozolomide in HGG

RecruitingPhase 2
  • Susan Chi, Boston
Ages 12 to 39 · All sexes · Updated Sep 1, 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Research Site, Boston
Ages 18 to 130 · All sexes · Updated Aug 12, 2026 · NCT05417594

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RecruitingEarly phase 1Healthy volunteers welcome
  • Dana-Farber Cancer Institute, Boston
Ages 1 to 21 · All sexes · Updated Jun 29, 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · All sexes · Updated May 29, 2026 · NCT05843253

Implantable Microdevice In Primary Brain Tumors

RecruitingEarly phase 1
  • Brigham and Women's Hospital, Boston
Ages 18 and older · All sexes · Updated Jul 23, 2025 · NCT04135807

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

RecruitingObservational study
  • Massachusetts General Hospital, Boston
Ages 18 to 90 · All sexes · Updated Feb 28, 2024 · NCT06283927

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

RecruitingObservational study
  • Massachusetts General Hospital, Boston
Up to age 90 · All sexes · Updated Feb 22, 2024 · NCT06273176

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

RecruitingObservational study
  • Massachusetts General Hospital, Boston
Ages 18 to 90 · All sexes · Updated Feb 22, 2024 · NCT06118723

Astrocytoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.